Gts Securities LLC Ginkgo Bioworks Holdings, Inc. Put Options Transaction History

Gts Securities LLC

  • $45.4 Billion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.28 - $1.16 $5,376 - $22,272
-19,200 Reduced 23.85%
61,300 $20,000
Q1 2024

May 15, 2024
SELL
$1.06 - $1.67 $9,858 - $15,531
-9,300 Reduced 10.36%
80,500 $93,000
Q4 2023

Feb 14, 2024
BUY
$1.26 - $1.79 $39,564 - $56,206
31,400 Added 53.77%
89,800 $151,000
Q3 2023

Nov 15, 2023
BUY
$1.61 - $2.54 $94,024 - $148,336
58,400 New
58,400 $105,000

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $13.2B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email